L26/P-198 PIEZO-assisted intracytoplasmic sperm injection(ICSI) improves developmental potential and clinical outcomes of vitrified-warmed human oocytes
Human Reproduction · 01.07.2026 · 41 (Supplement_1)
DOI: 10.1093/humrep/deag083.534 ↗Kurz gefasst
Fachartikel in der Zeitschrift Human Reproduction, online erschienen am 08.07.2026. Verfasst von W. Choi und 6 weiteren Autor:innen.
Abstract (Originalsprache)
Study question Can PIEZO-assisted ICSI improve fertilization and clinical outcomes in vitrified-warmed human oocytes by reducing mechanical stress and oolemma disruption compared with conventional ICSI? Summary answer Piezo-assisted intracytoplasmic sperm injection reduced oocyte lysis and improved fertilization, blastocyst formation, and clinical pregnancy rates in vitrified-warmed oocytes compared with conventional technique. What is known already Oocyte vitrification is a key component of fertility preservation but may increase oolemma rigidity and cytoplasmic fragility, making warmed oocytes more vulnerable to injection-related trauma. Conventional ICSI relies on negative pressure to penetrate the oolemma, which can cause cytoplasmic displacement, membrane damage, and oocyte lysis. PIEZO-assisted ICSI uses high-frequency microvibrations to traverse the oolemma with minimal aspiration, potentially reducing mechanical stress. While improved performance of PIEZO ICSI has been reported in fresh oocytes, evidence focusing on clinical and implantation outcomes using autologous vitrified-warmed oocytes is still limited. Study design, size, duration This was a retrospective comparative analysis performed between March 2020 and December 2024 at a single university-affiliated fertility center. Overall, 2,385 vitrified MII oocytes from 263 cycles were reviewed. A subset analysis of 150 warmed autologous oocytes from 13 embryo transfer cycles was used for a direct comparison between conventional ICSI (n = 75 oocytes, 6 cycles) and PIEZO-assisted ICSI (n = 75 oocytes, 7 cycles). Participants/materials, setting, methods After standardized vitrification-warming, surviving autologous MII oocytes underwent either conventional ICSI or PIEZO-assisted ICSI according to the laboratory protocol. PIEZO-actuated micropipettes enabled membrane penetration with minimal or no suction-based aspiration. Outcome measures included fertilization rate, oocyte lysis rate, blastocyst formation rate, clinical pregnancy rate, and implantation rate per embryo transferred. Baseline patient and cycle characteristics were compared to exclude major confounding. Statistical analyses were performed using Chi-square and Fisher’s exact tests, as appropriate Main results and the role of chance In the sub-cohort of 150 warmed oocytes, the PIEZO ICSI group showed a higher fertilization rate than the conventional ICSI group (86.67% vs. 62.06%, P < 0.05) and a lower oocyte lysis rate (4.53% vs. 13.79%, P < 0.05). Blastocyst formation was also higher with PIEZO ICSI (30.0% vs. 8.33%, P < 0.05). At the clinical level, cycles using PIEZO ICSI achieved higher clinical pregnancy rates (77.78% vs. 37.50%, P < 0.001) and implantation rates (43.75% vs. 18.75%, P < 0.001) compared with cycles using conventional ICSI. Baseline characteristics were similar between the two groups, supporting the interpretation that the observed differences are unlikely to be explained by patient selection alone. The consistency of the improvements across intermediate (lysis, fertilization, blastocyst) and clinical (pregnancy, implantation) endpoints suggests a limited role of chance, although the small number of transfer cycles requires cautious interpretation. Limitations, reasons for caution This retrospective analysis, limited by a small number of embryo transfer cycles (n = 13) and single-center protocols, restricts statistical power and generalizability. Validation through larger, prospective, multicenter randomized studies is required to confirm these findings and further evaluate ongoing pregnancy and live birth outcomes. Wider implications of the findings As oocyte cryopreservation becomes integral to assisted reproduction, refining injection techniques for vitrified-warmed oocytes is clinically important. Piezo-assisted intracytoplasmic sperm injection may offer a less invasive approach, enhancing developmental potential and improving live birth outcomes, particularly in centers with high volumes of fertility preservation and elective freezing cycles. Trial registration number No
Zitieren
APA
Choi, W., Cha, H., Kim, G., Kim, H., Lim, C., Shin, S., & Lee, K. (2026). L26/P-198 PIEZO-assisted intracytoplasmic sperm injection(ICSI) improves developmental potential and clinical outcomes of vitrified-warmed human oocytes. Human Reproduction, 41(Supplement_1). https://doi.org/10.1093/humrep/deag083.534
Vancouver
Choi W, Cha H, Kim G, Kim H, Lim C, Shin S, et al. L26/P-198 PIEZO-assisted intracytoplasmic sperm injection(ICSI) improves developmental potential and clinical outcomes of vitrified-warmed human oocytes. Human Reproduction. 2026;41(Supplement_1). doi:10.1093/humrep/deag083.534
BibTeX
@article{Choi2026,
author = {Choi, W. and Cha, H.J. and Kim, G.W. and Kim, H.Y. and Lim, C.K. and Shin, S.H. and Lee, K.E.},
title = {L26/P-198 PIEZO-assisted intracytoplasmic sperm injection(ICSI) improves developmental potential and clinical outcomes of vitrified-warmed human oocytes},
journal = {Human Reproduction},
year = {2026},
volume = {41},
number = {Supplement_1},
doi = {10.1093/humrep/deag083.534}
}
EUVIMED